0000899243-22-028250.txt : 20220810
0000899243-22-028250.hdr.sgml : 20220810
20220810160729
ACCESSION NUMBER: 0000899243-22-028250
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220808
FILED AS OF DATE: 20220810
DATE AS OF CHANGE: 20220810
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bhatia Sangeeta N.
CENTRAL INDEX KEY: 0001643921
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 221151862
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS, INC.
STREET 2: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-08-08
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001643921
Bhatia Sangeeta N.
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
0
0
0
Common Stock
2022-08-08
4
S
0
45
290.18
D
5237
D
Common Stock
2022-08-08
4
S
0
164
291.76
D
5073
D
Common Stock
2022-08-08
4
S
0
204
293.15
D
4869
D
Common Stock
2022-08-08
4
S
0
161
294.24
D
4708
D
Common Stock
2022-08-08
4
S
0
47
295.53
D
4661
D
Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1.
Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $290.18 (range $290.05 to $290.20).
Open market sales reported on this line occurred at a weighted average price of $291.76 (range $291.59 to $291.91).
Open market sales reported on this line occurred at a weighted average price of $293.15 (range $292.71 to $293.61).
Open market sales reported on this line occurred at a weighted average price of $294.24 (range $293.85 to $294.49).
/s/ Joy Liu, Attorney-in-Fact
2022-08-10